baf complexes facilitate decatenation dna topoisomerase ii alpha 
recent exon-sequencing studies human tumours revealed subunits baf mammalian swi/snf complexes mutated % human malignancies mechanisms involved tumour suppression unclear baf chromatin-remodelling complexes polymorphic assemblies use energy provided atp hydrolysis regulate transcription control chromatin structure placement polycomb repressive complex prc2 across genome several proteins dedicated multisubunit complex including brg1 also known smarca4 baf250a also known arid1a mutated frequencies similar recognized tumour suppressors particular core atpase brg1 mutated % childhood medulloblastomas- % burkitts lymphomas show previously unknown function baf complexes decatenating newly replicated sister chromatids requirement proper chromosome segregation mitosis find deletion brg1 mouse cells well expression brg1 point mutants identified human tumours leads anaphase bridge formation sister chromatids linked catenated strands dna g2/m-phase block characteristic decatenation checkpoint endogenous baf complexes interact directly endogenous topoisomerase ii alpha top2a baf250a required binding top2a approximately sites across genome results demonstrate top2a chromatin binding dependent atpase activity brg1 compromised oncogenic brg1 mutants studies indicate ability top2a prevent dna entanglement mitosis requires baf complexes suggest activity contributes role baf subunits tumour suppressors 
